PHARMACOKINETICS OF CLARITHROMYCIN IN THE PROSTATE: IMPLICATIONS FOR THE TREATMENT OF CHRONIC ABACTERIAL PROSTATITIS

Abstract

The oral administration of clarithromycin achieved a prostate level much higher than the minimal inhibitory concentration of clarithromycin for the intracellular pathogens of chronic prostatitis. Thus, clarithromycin may be considered for treating chronic abacterial prostatitis.